Thursday, March 28, 2024
Home Tags Nasdaq:APLS

Tag: Nasdaq:APLS

Apellis Announces U.S. Food and Drug Administration (FDA) Approval of EMPAVELI™...

0
EMPAVELI, the first targeted C3 therapy, is approved for use in adults with PNH who are:Treatment naïveSwitching from C5 inhibitor Soliris® (eculizumab) Switching...

Apellis to Present Long-Term Pegcetacoplan Data in PNH at the European...

0
Seven accepted abstracts, including an oral presentation, reinforce the potential of pegcetacoplan, an investigational, targeted C3 therapy, to redefine treatment for patients with...

Apellis to Showcase Leadership in Retina at Association for Research in...

0
10 accepted abstracts include five oral presentations from pioneering artificial intelligence (AI) collaboration Presentations support the potential of intravitreal pegcetacoplan, an investigational targeted...

Press Realease

Business News

Cricket

Weather News

Lifestyle

World News

UK / USA News

Local News